Long-term safety data, including pancreatitis risk, gallbladder events, and any potential thyroid C-cell findings, will continue to accumulate through the Phase 3 TRIUMPH program
If you're taking semaglutide and feeling like you could fall asleep standing up, welcome to the clubyou've got plenty of company
Starting at 5 mg instead of 2.5 mg Some providers start patients at 5 mg when: The patient was on maximum-dose semaglutide (2.0 to 2.4 mg) for 6 or more months with good tolerance The patient experienced no significant GI side effects on semaglutide Weight loss has been stalled for 8 or more weeks despite medication compliance The patient has a BMI above 40 and more aggressive weight loss is clinically appropriate A study examining GLP-1 to tirzepatide transitions found that patients who started at 5 mg had manageable side effects and comparable outcomes to those who started at 2.5 mg, provided they had prior GLP-1 experience
However, because BPC-157 has not been approved by the FDA for any medical use, it cannot be legally marketed as a drug or sold as a dietary supplement
Recent Updates November 21, 2025: Updated Sheds information to reflect price cut in premium coaching program and new membership costs with Wegovy and Zepbound